ALIMABALOXAVIR

COMPOSITION
Baloxavir Marboxil………………………………20mg
INDICATION
• Treatment of acute uncomplicated influenza in patients 12 years of age or older who have been symptomatic for no more than 48 hours and who are otherwise healthy.
• Adults and pediatric patients 12 years of age and older who are at high risk of developing influenza-related complications.
• Post-exposure prophylaxis of influenza in patients 5 years of age and older following contact with an individual who has influenza.
PACKAGING:
• 2 tablets/blister pack, 1 blister pack/box.

Reg No: 11 L 1272/24
Download ALIMABALOXAVIR Drug Registration Certificate

Brand name: ALIMABALOXAVIR


Composition:
Each tablet contains:
Baloxavir Marboxil………………………………20mg


Indications:
• Treatment of acute uncomplicated influenza in patients 12 years of age or older who have been symptomatic for no more than 48 hours and who are otherwise healthy.
• Adults and pediatric patients 12 years of age and older who are at high risk of developing influenza-related complications.
• Post-exposure prophylaxis of influenza in patients 5 years of age and older following contact with an individual who has influenza.


Dosage:
This product should be taken as a single dose as soon as possible and within 48 hours of influenza symptom onset for treatment of acute uncomplicated influenza or following contact with an individual who has influenza.
• Patients weighing between 20kg-80kg: 40mg.
• Patients weighing≥80kg: 80mg.


Contraindications: Allergic to any component of this product.


Warnings:
• If there is a suspected allergic reaction during the medication process, stop the medication immediately and take treatment.
• This product is not suitable for patients under 5 years old.
• There is no research to prove that this product is effective against pathogens other than influenza virus. Be cautious of secondary bacterial infections.
• Pregnant and lactating women should use with caution.


Adverse Effects: Diarrhea, bronchitis, nausea, sinusitis, headache, vomiting.


Dosage form: Yellow tablets.


Expiry date: 24 months from the date of manufacture.


Packaging: 2 tablets/blister pack, 1 blister pack/box.


Storage:
• Protected from light, sealed in original packaging, and stored at 20℃- 25℃.
• Keep out of reach of children.


DISCLAIMER

The information on this website about our medications is intended for general educational purposes only and should not be considered a substitute for professional medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay seeking care because of something you have read on this website.

For your safety:

Do not self-diagnose or treat any medical condition based solely on the information on this website. If you have any questions or concerns about a medication, please talk to your doctor or pharmacist.